Biotech · Private company
Clementia Pharmaceuticals Inc.
Track this companyFree. Adds Clementia Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials80 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- PalovarotenePhase 3 · Fibrodysplasia Ossificans ProgressivaClinicalTrials.gov · fetched Nov 12, 2026
- IPN60130Phase 2 · Fibrodysplasia Ossificans ProgressivaClinicalTrials.gov · fetched Nov 12, 2026
- Palovarotene 2.5 mgPhase 2 · Exostoses, Multiple HereditaryClinicalTrials.gov · fetched Nov 12, 2026
- Palovarotene 5.0 mgPhase 2 · Exostoses, Multiple HereditaryClinicalTrials.gov · fetched Nov 12, 2026
- Palovarotene dose level 1Phase 2 · Fibrodysplasia Ossificans ProgressivaClinicalTrials.gov · fetched Nov 12, 2026
- Palovarotene dose level 2Phase 2 · Fibrodysplasia Ossificans ProgressivaClinicalTrials.gov · fetched Nov 12, 2026
- Palovarotene dose level 3Phase 2 · Fibrodysplasia Ossificans ProgressivaClinicalTrials.gov · fetched Nov 12, 2026
- Palovarotene dose level 4Phase 2 · Fibrodysplasia Ossificans ProgressivaClinicalTrials.gov · fetched Nov 12, 2026
- midazolamPhase 1 · Fibrodysplasia Ossificans ProgressivaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).PHASE2 · TERMINATED · started Dec 1, 2021ClinicalTrials.gov NCT05039515 · fetched Nov 12, 2026
- Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in Two Cohorts of Healthy Adult SubjectsPHASE1 · COMPLETED · started Jan 3, 2019ClinicalTrials.gov NCT04829773 · fetched Nov 12, 2026
- An Efficacy and Safety Study of Palovarotene for the Treatment of MOPHASE2 · TERMINATED · started Mar 22, 2018ClinicalTrials.gov NCT03442985 · fetched Nov 12, 2026
- An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.PHASE3 · COMPLETED · started Nov 30, 2017ClinicalTrials.gov NCT03312634 · fetched Nov 12, 2026
- In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) SubjectsPHASE2 · TERMINATED · started Dec 7, 2015ClinicalTrials.gov NCT02521792 · fetched Nov 12, 2026
- A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)COMPLETED · started Dec 18, 2014ClinicalTrials.gov NCT02322255 · fetched Nov 12, 2026
- An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)PHASE2 · COMPLETED · started Oct 9, 2014ClinicalTrials.gov NCT02279095 · fetched Nov 12, 2026
- An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP SubjectsPHASE2 · COMPLETED · started Jul 14, 2014ClinicalTrials.gov NCT02190747 · fetched Nov 12, 2026